Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Journal of the American Society of Nephrology : JASN|November 10, 2020
Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in AdultsHo Jun Chin, Dong-Wan Chae, Yong Chul Kim, et al.
Scientific Reports|July 14, 2026
Prognostic effect of changes in high-density lipoprotein cholesterol after kidney transplantationJeong-Hoon Lim, Hyun Tae Kim, Sik Lee, et al.
Current Medical Research and Opinion|December 21, 2018
Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysisJong Hoon Lee, Byung Ha Chung, Kwon Wook Joo, et al.
Blood Purification|September 3, 2015
Serum Ferritin Predicts Mortality Regardless of Inflammatory and Nutritional Status in Patients Starting Dialysis: A Prospective Cohort StudyKyoung Sook Park, Geun Woo Ryu, Jong Hyun Jhee, et al.
Critical Care Medicine|December 10, 2024
Sex-Specific Obesity Paradox in Critically Ill Patients With Severe Acute Kidney Injury: A Retrospective AnalysisHyo Jin Jung, Yu Jin Seo, Jiyun Jung, et al.
Kidney International Reports|August 19, 2024
Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched StudyJeong-Hoon Lim, Soie Kwon, Yu Jin Seo, et al.
Kidney Research and Clinical Practice|July 8, 2026
Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trialEun Jeong Ko, Mi-Sun Byun, Chul Woo Yang, et al.
Kidney Research and Clinical Practice|January 12, 2023
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration periodHyuk Huh, Yong Soo Kim, Wookyung Chung, et al.
Kidney Research and Clinical Practice|October 9, 2024
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final reportHayne Cho Park, Yong Chul Kim, Hyunsuk Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2019
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III StudyYaerim Kim, Su-Kil Park, Won Yong Cho, et al.
Pageof 28